547 related articles for article (PubMed ID: 1282631)
1. Role of endothelium-derived bradykinin in the control of vascular tone.
Hecker M; Dambacher T; Busse R
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
[TBL] [Abstract][Full Text] [Related]
2. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
Busse R; Fleming I; Hecker M
J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.
Hecker M; Bara AT; Busse R
Eur Heart J; 1993 Nov; 14 Suppl I():161-3. PubMed ID: 8293768
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of endothelial autacoid formation by inhibitors of angiotensin-converting enzyme.
Hecker M; Benzing T; Busse R
Agents Actions Suppl; 1992; 38 ( Pt 3)():163-70. PubMed ID: 1281378
[TBL] [Abstract][Full Text] [Related]
5. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
Hecker M; Pörsti I; Bara AT; Busse R
Br J Pharmacol; 1994 Jan; 111(1):238-44. PubMed ID: 8012702
[TBL] [Abstract][Full Text] [Related]
6. Relaxation of isolated coronary arteries by angiotensin-converting enzyme inhibitors: role of endothelium-derived kinins.
Hecker M; Bara AT; Busse R
J Vasc Res; 1993; 30(5):257-62. PubMed ID: 8399986
[TBL] [Abstract][Full Text] [Related]
7. Converting enzyme inhibitor-stimulated formation of nitric oxide and prostacyclin in endothelial cells from bovine aorta is mediated by endothelium-derived bradykinin.
Wiemer G; Schölkens BA; Becker RH
Agents Actions Suppl; 1992; 38 ( Pt 3)():196-200. PubMed ID: 1334350
[TBL] [Abstract][Full Text] [Related]
8. Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S62-7. PubMed ID: 1282632
[TBL] [Abstract][Full Text] [Related]
9. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.
Wiemer G; Schölkens BA; Becker RH; Busse R
Hypertension; 1991 Oct; 18(4):558-63. PubMed ID: 1655653
[TBL] [Abstract][Full Text] [Related]
10. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells.
Wiemer G; Popp R; Schölkens BA; Gögelein H
Brain Res; 1994 Feb; 638(1-2):261-6. PubMed ID: 7515323
[TBL] [Abstract][Full Text] [Related]
12. Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors.
Auch-Schwelk W; Kuchenbuch C; Claus M; Walther B; Bossaller C; Friedel N; Graf K; Gräfe M; Fleck E
Eur Heart J; 1993 Nov; 14 Suppl I():154-60. PubMed ID: 8293767
[TBL] [Abstract][Full Text] [Related]
13. ACE inhibitor potentiation of bradykinin-induced venoconstriction.
Hecker M; Blaukat A; Bara AT; Müller-Esterl W; Busse R
Br J Pharmacol; 1997 Aug; 121(7):1475-81. PubMed ID: 9257930
[TBL] [Abstract][Full Text] [Related]
14. Effects of converting enzyme inhibition on endothelial bradykinin metabolism and endothelium-dependent vascular relaxation.
Bossaller C; Auch-Schwelk W; Gräfe M; Graf K; Baumgarten C; Fleck E
Agents Actions Suppl; 1992; 38 ( Pt 3)():171-7. PubMed ID: 1334349
[TBL] [Abstract][Full Text] [Related]
15. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
Henrion D; Dechaux E; Dowell FJ; Maclour J; Samuel JL; Lévy BI; Michel JB
Br J Pharmacol; 1997 May; 121(1):83-90. PubMed ID: 9146891
[TBL] [Abstract][Full Text] [Related]
16. NO/PGI2-independent vasorelaxation and the cytochrome P450 pathway in rabbit carotid artery.
Dong H; Waldron GJ; Galipeau D; Cole WC; Triggle CR
Br J Pharmacol; 1997 Feb; 120(4):695-701. PubMed ID: 9051310
[TBL] [Abstract][Full Text] [Related]
17. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
Linz W; Schölkens BA
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
[TBL] [Abstract][Full Text] [Related]
18. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts.
Linz W; Wiemer G; Schölkens BA
J Mol Cell Cardiol; 1992 Aug; 24(8):909-19. PubMed ID: 1331474
[TBL] [Abstract][Full Text] [Related]
19. L-type Ca2+ channels are not involved in coronary endothelial Ca2+ influx mechanism responsible for endothelium-dependent relaxation.
Uchida H; Tanaka Y; Ishii K; Nakayama K
Res Commun Mol Pathol Pharmacol; 1999; 104(2):127-44. PubMed ID: 10634306
[TBL] [Abstract][Full Text] [Related]
20. Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure.
Zhang X; Recchia FA; Bernstein R; Xu X; Nasjletti A; Hintze TH
J Pharmacol Exp Ther; 1999 Feb; 288(2):742-51. PubMed ID: 9918584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]